These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32958439)
1. Mortality in STEMI Patients During the COVID Era: Has the Pandemic Changed Our Clinical Practice? Barbieri L; Tumminello G; Lucreziotti S; Gentile D; Centola M; Conconi B; Carlà M; Mafrici A; Carugo S Cardiovasc Revasc Med; 2021 Jan; 22():120-121. PubMed ID: 32958439 [No Abstract] [Full Text] [Related]
2. Experience of ST Segment Elevation Myocardial Infarction Management During COVID-19 Pandemic From the Mainland of China. Zhang F; Song X; Dang Y Cardiovasc Revasc Med; 2021 Jul; 28():92-94. PubMed ID: 32855085 [TBL] [Abstract][Full Text] [Related]
3. The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China. Lu Q; Wang JL; Chen ZN; Fu WB; Liu HJ; Ding SF Rev Cardiovasc Med; 2021 Mar; 22(1):247-256. PubMed ID: 33792269 [TBL] [Abstract][Full Text] [Related]
4. Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic. Medranda GA; Brahmbhatt K; Alawneh B; Marzo KP; Schwartz RK; Green SJ Cardiovasc Revasc Med; 2022 Jan; 34():80-85. PubMed ID: 33526393 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020. Nan J; Meng S; Hu H; Jia R; Chen W; Li Q; Zhang T; Song K; Wang Y; Jin Z Med Sci Monit; 2020 Sep; 26():e927061. PubMed ID: 32938901 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York. Hannan EL; Wu Y; Cozzens K; Friedrich M; Tamis-Holland J; Jacobs AK; Ling FSK; King SB; Venditti FJ; Walford G; Berger PB; Kirtane AJ; Kamran M Am J Cardiol; 2021 Mar; 142():25-34. PubMed ID: 33301770 [TBL] [Abstract][Full Text] [Related]
7. Lessons learned from reduced acute cardiovascular events and STEMI during Covid-19. Sharma SK; Fuster V; Hofstra L; Kini AS; Gianelli A; Narula J Catheter Cardiovasc Interv; 2021 Apr; 97(5):850-852. PubMed ID: 32881289 [No Abstract] [Full Text] [Related]
8. A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19. Ghasemzadeh N; Kim N; Amlani S; Madan M; Shavadia JS; Chong AY; Bagherli A; Bagai A; Saw J; Singh J; Dehghani P Cardiol Clin; 2022 Aug; 40(3):321-328. PubMed ID: 35851455 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of patients with ST-segment elevated myocardial infarction (STEMI) at the initial stage of the COVID-19 pandemic: a systematic review and meta-analysis. Zhu Y; Xing W; Wang H; Song J; Sun Z; Li X Infect Dis (Lond); 2021 Nov; 53(11):865-875. PubMed ID: 34311652 [TBL] [Abstract][Full Text] [Related]
10. Mechanical complications after STEMI: Another collateral damage of the COVID-19 pandemic. Holzknecht M; Klug G; Metzler B; Reinstadler SJ Int J Cardiol; 2022 Feb; 348():23-25. PubMed ID: 34864082 [No Abstract] [Full Text] [Related]
12. Practice patterns for patients with ST-elevation myocardial infarction during the early phase of the COVID-19 pandemic-Valuable lessons learned. Jia X; Jneid H Catheter Cardiovasc Interv; 2021 Aug; 98(2):223-224. PubMed ID: 34369060 [TBL] [Abstract][Full Text] [Related]
13. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes. Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109 [No Abstract] [Full Text] [Related]
14. The STEMI phenomenon during the COVID-19 pandemic: what is beneath the tip of the iceberg? Cammann VL; Templin C Heart; 2022 Mar; 108(6):412-413. PubMed ID: 35078870 [No Abstract] [Full Text] [Related]
15. A new dimension to the STEMI-related mortality risk seen in the COVID-19 pandemic era. Jolobe OMP Am J Emerg Med; 2022 Oct; 60():189-192. PubMed ID: 35750530 [No Abstract] [Full Text] [Related]
16. Treatment Challenges of ST-Segment Elevation Myocardial Infarction Within the Constraint of COVID-19 Pandemic. Shereef H; Yassin AS; Subahi A; Ali O Am J Ther; 2021 Nov-Dec 01; 28(6):e738-e740. PubMed ID: 34757967 [No Abstract] [Full Text] [Related]
17. Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic. Kow CS; Hasan SS J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):772-773. PubMed ID: 32798030 [No Abstract] [Full Text] [Related]
18. Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Çinier G; Hayıroğlu M; Pay L; Yumurtaş A; Tezen O; Parsova KE; Tekkesin I Turk Kardiyol Dern Ars; 2020 Oct; 48(7):640-645. PubMed ID: 33034585 [TBL] [Abstract][Full Text] [Related]
19. Standards of Care in Crisis: ST-Segment-Elevation Myocardial Infarction Management in COVID-19. Mihatov N; Kirtane AJ Circ Cardiovasc Interv; 2020 Nov; 13(11):e010143. PubMed ID: 33167704 [No Abstract] [Full Text] [Related]
20. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual? Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225 [No Abstract] [Full Text] [Related] [Next] [New Search]